Urologic Oncology Research Symposium

Forum

Information

Independent educational grant support provided by: AstraZeneca and Merck

Of Interest To
Researchers

Details

Welcome and Opening Remarks

Friday, September 10, 2021 8:00 PM to 8:10 PM
James Brooks · Stanford School of Med. Dept. of Urology

Session One: Prostate – Moderator’s Introduction

Friday, September 10, 2021 8:10 PM to 8:15 PM
Brian Helfand · NorthShore University HealthSystem

Germline Genetics for Prostate Cancer Screening: Utility of Monogenic and Polygenic Tests for Identification of High Risk Individuals

Friday, September 10, 2021 8:15 PM to 8:25 PM
Jianfeng Xu · Northshore University Healthsystem

Germline Genetics for Prostate Cancer Prognosis: Predicting Drug Treatment Response for Men with Advanced Prostate Cancer

Friday, September 10, 2021 8:25 PM to 8:35 PM
Heather Cheng

Somatic Genetics for Predicting Disease Response and Aggressiveness: When Should We Consider Tumor Analysis?

Friday, September 10, 2021 8:35 PM to 8:45 PM
Christopher Barbieri

Session Two: Bladder – Moderator’s Introduction

Friday, September 10, 2021 8:45 PM to 8:50 PM
Joshua Meeks

The Role of Somatic Mutations and Germline Evaluation in Urothelial Cancer Progression

Friday, September 10, 2021 8:50 PM to 9:00 PM
Bishoy Faltas · Weill Cornell Medicine

RNA-Based Biomarkers for Precision Oncology in Urothelial Cancer

Friday, September 10, 2021 9:00 PM to 9:10 PM
Seth Lerner · Baylor College Of Medidineieôww

Integrating Gender and Hormone Status in Biomarkers for Urothelial Cancer

Friday, September 10, 2021 9:10 PM to 9:20 PM
Sima Porten

ctDNA to Guide Treatment in Urothelial Cancer

Friday, September 10, 2021 9:20 PM to 9:30 PM

Urinary Biomarkers to Improve Urothelial Cancer Surveillance and Treatment Response Assessment

Friday, September 10, 2021 9:30 PM to 9:40 PM
Joseph Liao · Stanford School of Med Dept of Urology

Break

Friday, September 10, 2021 9:40 PM to 9:55 PM

Integrating Molecular Analysis with Clinical Decision Making for Patients with Renal Cell Cancer

Friday, September 10, 2021 9:55 PM to 10:05 PM
Joshua Lang · University of Wisconsin

Defining RCC Subtypes Using Genomic Alterations

Friday, September 10, 2021 10:05 PM to 10:15 PM

Distinguishing Benign Renal Tumors from RCC Using Gene Expression Biomarkers

Friday, September 10, 2021 10:15 PM to 10:25 PM
Brian Shuch

Introduction of Keynote Talk

Friday, September 10, 2021 10:25 PM to 10:30 PM
Daniel Lin

Keynote Talk: Biomarker-Based Personalization of Therapy for Prostate Cancer Patients: Current Trends and Future Directions

Friday, September 10, 2021 10:30 PM to 10:50 PM